Why the study?
The molecular mechanism of developmental cardiac defects in offspring resulting from pregestational diabetes remains unclear.
Does maternal pregestational diabetes alter cardiac structure, function, and gene expression in neonatal rats?
Does maternal pregestational diabetes alter cardiac structure, function, and gene expression in neonatal rats?
Maternal pregestational diabetes induces significant structural, functional, and transcriptomic alterations in the neonatal rat heart, providing a molecular basis for diabetic embryopathy-associated congenital heart defects.
PGDM-exposed neonatal hearts exhibit remodeling via plasticity; leaves open translation to human offspring risk and monitoring needs.
Pregestational diabetes (PGDM) leads to developmental impairment, especially cardiac dysfunction, in their offspring. The hyperglycemic microenvironment inside the uterus alters the cardiac plasticity characterized by electrical and structural remodeling of the heart. The altered expression of several transcription factors due to hyperglycemia during fetal development might be responsible for molecular defects and phenotypic changes in the heart. The molecular mechanism of the developmental defects in the heart due to PGDM remains unclear. To understand the molecular defects in the 2-days old neonatal rats, streptozotocin-induced diabetic female rats were bred with healthy male rats. We collected 2-day-old hearts from the neonates and identified the molecular basis for phenotypic changes. Neonates from diabetic mothers showed altered electrocardiography and echocardiography parameters. Transcriptomic profiling of the RNA-seq data revealed that several altered genes were associated with heart development, myocardial fibrosis, cardiac conduction, and cell proliferation. Histopathology data showed the presence of focal cardiac fibrosis and increased cell proliferation in neonates from diabetic mothers. Thus, our results provide a comprehensive map of the cellular events and molecular pathways perturbed in the neonatal heart during PGDM. All of the molecular and structural changes lead to developmental plasticity in neonatal rat hearts and develop cardiac anomalies in their early life.
No takes yet. Share an insight, caveat, or question.
Alam et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: